Learn More
Invitrogen™ INSR Monoclonal Antibody (CT-3)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA513783
Description
MA5-13783 targets Insulin Receptor beta in ELISA, ICC/IF, IHC (P), Affinity Purification, and WB applications and shows reactivity with Human, mouse, Non-human primate, and Rat samples. The MA5-13783 immunogen is recombinant-fragment including the C-terminal 100 amino acids of human insulin receptor.
INSR is a receptor tyrosine kinase. Binding of insulin to the extracellular domain of INSR stimulates glucose uptake. INSR and IGF-1 receptors share major structural and functional similarity. The earliest cellular response to insulin stimulation is autophosphorylation of tyrosine in INSR. In humans, the INSR gene is located on chromosome 19. Defects in INSR are the cause of various insulin resistance syndromes and IGF-1R defects may also cause some forms of growth retardation.
Specifications
INSR | |
Monoclonal | |
0.2 mg/mL | |
PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4 | |
P06213, P15208 | |
INSR | |
Recombinant-fragment including the C-terminal 100 amino acids of human insulin receptor. | |
500 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG1 |
Affinity Purification, ELISA, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
CT-3 | |
Unconjugated | |
INSR | |
4932439J01Rik; CD 220; CD220; CD220 antigen; CD220 beta; CD221; D630014A15Rik; HHF 5; HHF5; IGF-I receptor; INSR; Insulin receptor; insulin receptor preproprotein; Insulin receptor subunit alpha; Insulin receptor subunit beta; IR; IR 1; IR beta; IR1; IR-1; IR-A; IR-B | |
Mouse | |
Protein G | |
RUO | |
16337, 3643 | |
4°C | |
Liquid |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.